C-Src, ERK1/2 and Rho kinasemediate hydrogen peroxide-induced vascular contraction in hypertension: Role ofTXA2, NAD(P)H oxidase andmitochondria

Journal of Hypertension

Volumn 33, Issue 1, 2015, Pages 77-87

  García Redondo, Ana B ^a   Briones, Ana M ^a   Martínez Revelles, Sonia ^a   Palao, Teresa ^a   Vila, Luis ^b   Alonso, María J ^c   Salaices, Mercedes ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^c UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

C Src; ERK1 2; H2O2; Mesenteric resistance arteries; Mitochondria; NAD(P)H oxidase; Rho kinase; Spontaneously hypertensive rats

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CSK TYROSINE-PROTEIN KINASE; HYDROGEN PEROXIDE; PROTEIN TYROSINE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO KINASE; THROMBOXANE A2; VASOCONSTRICTOR AGENT;

ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; ENZYMOLOGY; HYPERTENSION; MALE; MESENTERIC ARTERY; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WISTAR KYOTO RAT;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; HYDROGEN PEROXIDE; HYPERTENSION; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MESENTERIC ARTERIES; MITOCHONDRIA; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; THROMBOXANE A2; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84916928817     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000383     Document Type: Article

References (47)

1. Ardanaz N, Pagano PJ. Hydrogen peroxide as a paracrine vascular mediator: Regulation and signaling leading to dysfunction. Exp Biol Med (Maywood) 2006; 231: 237-251.
2. Drummond GR, Selemidis S, Griendling KK, Sobey CG. Combating oxidative stress in vascular disease: NAD(P)H oxidases as therapeutic targets. Nat Rev Drug Discov 2011; 10: 453-471.
3. Briones AM, Touyz RM. Oxidative stress and hypertension: Current concepts. Curr Hypertens Rep 2010; 12: 135-142.
4. Gao YJ, Lee RM. Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. Br J Pharmacol 2001; 134: 1639-1646.
5. Cseko C, Bagi Z, Koller A. Biphasic effect of hydrogen peroxide on skeletal muscle arteriolar tone via activation of endothelial and smooth muscle signaling pathways. J Appl Physiol 2004; 97: 1130-1137.
6. 2+, and superoxide anion levels. J Pharmacol Exp Ther 2009; 328: 19-27.
7. García-Redondo AB, Briones AM, Avendaño MS, Hernanz R, Alonso MJ, Salaices M. Losartan and tempol treatments normalize the increased response to hydrogen peroxide in resistance arteries from hypertensive rats. J Hypertens 2009; 27: 1814-1822.
8. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schönbein GW, Parmer RJ. Plasmahydrogen peroxide production in human essential hypertension: Role of heredity, gender, and ethnicity. Hypertension 2000; 36: 878-884.
9. Zhang J, Youn JY, Kim AY, Ramirez RJ, Gao L, Ngo D, et al. NOX4-dependent hydrogen peroxide overproduction in human atrial fibrillation and HL-1 atrial cells: Relationship to hypertension. Front Physiol 2012; 3: 140.
10. Rodríguez-Martínez MA, García-Cohen EC, Baena AB, González R, Salaices M, Marín J. Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol 1998; 125: 1329-1335.
11. Thakali K, Davenport L, Fink GD, Watts SW. Pleiotropic effects of hydrogen peroxide in arteries and veins from normotensive and hypertensive rats. Hypertension 2006; 47: 482-487.
12. Dikalov SI, Nazarewicz RR. Angiotensin II-induced production of mitochondrial reactive oxygen species: Potential mechanisms and relevance for cardiovascular disease. Antioxid Redox Signal 2013; 19: 1085-1094.
13. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, et al. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 2010; 107: 106-116.
14. Martínez-Revelles S, Avendaño MS, García-Redondo AB, Alvarez Y, Aguado A, Pérez-Girón JV, et al. Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension. Antioxid Redox Signal 2013; 18: 51-65.
15. Dikalov SI, Nazarewicz RR, Bikineyeva A, Hilenski L, Lassègue B, Griendling KK, et al. Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. Antioxid Redox Signal 2014; 20: 281-294.
16. Gao YJ, Hirota S, Zhang DW, Janssen LJ, Lee RM. Mechanisms of hydrogen-peroxide-induced biphasic response in rat mesenteric artery. Br J Pharmacol 2003; 138: 1085-1092.
17. Bolla M, Matrougui K, Loufrani L, Maclouf J, Levy B, Levy-Toledano S, et al. p38 mitogen-Activated protein kinase activation is required for thromboxane-induced contraction in perfused and pressurized rat mesenteric resistance arteries. J Vasc Res 2002; 39: 353-360.
18. 2-induced vasoconstriction in the abdominal aorta and mesenteric artery of the mouse. Vascul Pharmacol 2007; 47: 288-294.
19. Thakali K, Davenport L, Fink GD, Watts SW. Cyclooxygenase, p38 mitogen-Activated protein kinase (MAPK), extracellular signalregulated kinase MAPK, Rho Kinase, and Src mediate hydrogen peroxide-induced contraction of rat thoracic aorta and vena cava. J Pharmacol Exp Ther 2007; 320: 236-243.
20. Denniss SG, Jeffery AJ, Rush JW. RhoA-Rho Kinase signaling mediates endothelium-And endoperoxide-dependent contractile activities characteristic of hypertensive vascular dysfunction. Am J Physiol Heart Circ Physiol 2010; 298: H1391-H1405.
21. Knock GA, Ward JP. Redox regulation of protein kinases as a modulator of vascular function. Antioxid Redox Signal 2011; 15: 1531-1547.
22. 2-induced vasoconstriction of rat coronary arteries. Free Radic Biol Med 2013; 60C: 136-146.
23. Tabet F, Schiffrin EL, Touyz RM. Mitogen-Activated protein kinase activation by hydrogen peroxide is mediated through tyrosine kinase-dependent, protein kinase C-independent pathways in vascular smooth muscle cells: Upregulation in spontaneously hypertensive rats. J Hypertens 2005; 23: 2005-2012.
24. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19-26.
25. Loirand G, Guérin P, Pacaud P. Rho Kinases in cardiovascular physiology and pathophysiology. Circ Res 2006; 98: 322-334.
26. 2-mediated injury of human endothelial cells. J Biol Chem 2000; 275: 37187-37193.
27. Saito S, Frank GD, Mifune M, Ohba M, Utsunomiya H, Motley ED, et al. Ligand-independent trans-Activation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase C-delta and c-Src. J Biol Chem 2002; 277: 44695-44700.
28. Zhang J, Xing D, Gao X. Low-power laser irradiation activates Src tyrosine kinase through reactive oxygen species-mediated signaling pathway. J Cell Physiol 2008; 217: 518-528.
29. Li Y, Lévesque LO, Anand-Srivastava MB. Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR. Am J Physiol Heart Circ Physiol 2010; 299: H1959-H1967.
30. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H Oxidase activity: Upstream mediators. Circ Res 2002; 91: 406-413.
31. Touyz RM, Yao G, Schiffrin EL. c-Src induces phosphorylation and translocation of p47phox: Role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003; 23: 981-987.
32. Romero M, Jiménez R, Sánchez M, López-Sepúlveda R, Zarzuelo A, Tamargo J, et al. Vascular superoxide production by endothelin-1 requires Src nonreceptor protein tyrosine kinase and MAPK activation. Atherosclerosis 2010; 212: 78-85.
33. Li WG, Miller FJ Jr, Zhang HJ, Spitz DR, Oberley LW, Weintraub NL. H(2)O(2)-induced O(2) production by a nonphagocytic NAD(P)H Oxidase causes oxidant injury. J Biol Chem 2001; 276: 29251-29256.
34. Goulopoulou S, Hannan JL, Matsumoto T, Webb RC. Pregnancy reduces RhoA/Rho kinase and protein kinase C signaling pathways downstream of thromboxane receptor activation in the rat uterine artery. Am J Physiol Heart Circ Physiol 2012; 302: H2477-H2488.
35. Ding L, Chapman A, Boyd R, Wang HD. ERK activation contributes to regulation of spontaneous contractile tone via superoxide anion in isolated rat aorta of angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 2007; 292: H2997-3005.
36. 2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003; 83: 1325-1358.
37. Mukai Y, Shimokawa H, Matoba T, Kandabashi T, Satoh S, Hiroki J, et al. Involvement of Rho-kinase in hypertensive vascular disease: A novel therapeutic target in hypertension. FASEB J 2001; 15: 1062-1064.
38. Seasholtz TM, Zhang T, Morissette MR, Howes AL, Yang AH, Brown JH. Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip1) expression in the vasculature of hypertensive rats. Circ Res 2001; 89: 488-495.
39. Nunes KP, Rigsby CS, Webb RC. RhoA/Rho-kinase and vascular diseases: What is the link? Cell Mol Life Sci 2010; 67: 3823-3836.
40. Jin L, Ying Z, Webb RC. Activation of Rho/Rho Kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol 2004; 287: H1495-H1500.
41. +) sensitization. Free Radic Biol Med 2009; 46: 633-642.
42. Chandra S, Romero MJ, Shatanawi A, Alkilany AM, Caldwell RB, Caldwell RW. Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho Kinase pathway. Br J Pharmacol 2012; 165: 506-519.
43. Asano M, Nomura Y. Comparison of inhibitory effects of Y-27632, a Rho Kinase inhibitor, in strips of small and large mesenteric arteries from spontaneously hypertensive and normotensive Wistar-Kyoto rats. Hypertens Res 2003; 26: 97-106.
44. 2+ release and PKC. Free Radic Biol Med 2008; 45: 1468-1476.
45. Satoh K, Fukumoto Y, Shimokawa H. Rho-kinase: Important new therapeutic target in cardiovascular diseases. Am J Physiol Heart Circ Physiol 2011; 301: H287-H296.
46. Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, et al. Long-Term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: Effect on endothelial NAD(P)H oxidase system. Circ Res 2003; 93: 767-775.
47. Touyz RM, He G, Wu XH, Park JB, Mabrouk ME, Schiffrin EL. Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension 2001; 38: 56-64.